Lenabasum 20 mg
Idiopathic Pulmonary Fibrosis
Clinical trials
2
Developer
Corbus Pharmaceuticals Inc.
Overview
Lenabasum 20 mg is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 2 tracked IPF clinical trials.
Lenabasum 20 mg clinical trials
Explore related
Medical disclaimer. This page summarizes research about Lenabasum 20 mg for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.